Alok Srivastava

18.4k total citations · 4 hit papers
416 papers, 10.5k citations indexed

About

Alok Srivastava is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Alok Srivastava has authored 416 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 266 papers in Hematology, 107 papers in Genetics and 89 papers in Molecular Biology. Recurrent topics in Alok Srivastava's work include Hemophilia Treatment and Research (106 papers), Hematopoietic Stem Cell Transplantation (68 papers) and Platelet Disorders and Treatments (57 papers). Alok Srivastava is often cited by papers focused on Hemophilia Treatment and Research (106 papers), Hematopoietic Stem Cell Transplantation (68 papers) and Platelet Disorders and Treatments (57 papers). Alok Srivastava collaborates with scholars based in India, United States and Canada. Alok Srivastava's co-authors include Mammen Chandy, Vikram Mathews, Biju George, Nigel S. Key, Johnny Mahlangu, Shaji R Velayudhan, Auro Viswabandya, Adolfo Llinás, Poonkuzhali Balasubramanian and H. Marijke van den Berg and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Alok Srivastava

387 papers receiving 10.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for the management of hemophilia

2012 1.4k citations Alok Srivastava, Adolfo Llinás et al. Haemophilia profile →
WFH Guidelines for the Management of Hemophilia, 3rd edition

2020 1.1k citations Alok Srivastava, Elena Santagostino et al. Haemophilia profile →
Definitions in hemophilia: communication from the SSC of the ISTH

2014 528 citations Victor S. Blanchette, H. Marijke van den Berg et al. Journal of Thrombosis and Haemostasis profile →
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial

2023 67 citations Alok Srivastava et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alok Srivastava India	46	8.0k	2.3k	2.2k	902	851	416	10.5k
Christine Mannhalter Austria	58	4.6k 0.6×	2.2k 1.0×	2.1k 1.0×	929 1.0×	1.8k 2.1×	338	10.9k
Yves Béguin Belgium	51	4.7k 0.6×	1.0k 0.5×	3.4k 1.6×	861 1.0×	1.5k 1.8×	368	9.4k
Giorgina Specchia Italy	48	4.1k 0.5×	2.8k 1.2×	2.3k 1.1×	937 1.0×	2.0k 2.3×	401	10.4k
Mrinal M. Patnaik United States	51	5.5k 0.7×	2.7k 1.2×	4.0k 1.8×	422 0.5×	875 1.0×	479	9.0k
Judith Marsh United Kingdom	52	6.6k 0.8×	964 0.4×	2.0k 0.9×	682 0.8×	1.8k 2.2×	210	9.1k
Ardeshir Ghavamzadeh Iran	36	2.0k 0.3×	2.3k 1.0×	2.0k 0.9×	1.1k 1.2×	1.0k 1.2×	363	6.5k
John A. Snowden United Kingdom	50	4.3k 0.5×	1.6k 0.7×	1.3k 0.6×	475 0.5×	2.8k 3.3×	261	9.1k
Barbara A. Konkle United States	41	4.2k 0.5×	1.6k 0.7×	904 0.4×	1.3k 1.4×	1.0k 1.2×	216	8.0k
Théo de Witte Netherlands	40	3.7k 0.5×	2.7k 1.2×	1.5k 0.7×	235 0.3×	1.1k 1.3×	137	7.0k
Shinichiro Okamoto Japan	41	3.3k 0.4×	1.1k 0.5×	1.3k 0.6×	674 0.7×	1.5k 1.7×	389	7.1k

Countries citing papers authored by Alok Srivastava

Since Specialization

Citations

This map shows the geographic impact of Alok Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alok Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alok Srivastava more than expected).

Fields of papers citing papers by Alok Srivastava

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alok Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alok Srivastava. The network helps show where Alok Srivastava may publish in the future.

Co-authorship network of co-authors of Alok Srivastava

This figure shows the co-authorship network connecting the top 25 collaborators of Alok Srivastava. A scholar is included among the top collaborators of Alok Srivastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alok Srivastava. Alok Srivastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chacko, Binila, John Victor Peter, Anand Zachariah, et al.. (2024). Biomarkers of coagulation, endothelial, platelet function, and fibrinolysis in patients with COVID-19: a prospective study. Scientific Reports. 14(1). 2011–2011. 8 indexed citations

Kumar, Pradeep, et al.. (2024). “Copper-loaded microplastics unleash endoplasmic reticulum stress-driven liver apoptosis in fish Channa punctatus”. Emerging contaminants. 11(1). 100422–100422. 11 indexed citations

Patel, Rajesh, et al.. (2024). Stability Analysis of Yield and Its Components in Snap Melon (Cucumis melo var momordica). International Journal of Environment and Climate Change. 14(8). 200–207. 1 indexed citations

Miesbach, Wolfgang, Barbara A. Konkle, Pratima Chowdary, et al.. (2024). Recommendations for a minimum data set for monitoring gene therapy in hemophilia: communication from the ISTH SSC Working Group on Gene Therapy. Journal of Thrombosis and Haemostasis. 22(5). 1510–1515. 5 indexed citations

Kulkarni, Uday, Anu Korula, Anup J. Devasia, et al.. (2022). Hematopoietic Stem Cell Transplantation is a cost-effective alternative to enzyme replacement therapy in Gaucher Disease. PubMed. 5(3). 69–74. 5 indexed citations

Daniel, Hubert Darius J., Sanjay Kumar, Rajesh Kannangai, et al.. (2022). Age‐stratified adeno‐associated virus serotype 3 neutralizing and total antibody prevalence in hemophilia A patients from India. Journal of Medical Virology. 94(9). 4542–4547. 4 indexed citations

Balasubramanian, P., Susanne Pulimood, Kavitha M. Lakshmi, et al.. (2021). Limited utility of plasma elafin as a biomarker for skin graft‐versus‐host disease following allogeneic stem cell transplantation. Clinical and Experimental Dermatology. 46(8). 1482–1487. 5 indexed citations

Srinivasan, Saranya, Sanjay Kumar, Srujan Marepally, et al.. (2021). Preferential Expansion of Human CD34 ⁺ CD133 ⁺ CD90 ⁺ Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy. Human Gene Therapy. 33(3-4). 188–201. 10 indexed citations

Srivastava, Alok, et al.. (2020). Prevention and treatment of COVID-19: An Ayurvedic intervention. international journal of green and herbal chemistry. 9(3). 1 indexed citations

10.

Srivastava, Alok, Elena Santagostino, Alison Dougall, et al.. (2020). WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 26(S6). 1–158. 1076 indexed citations breakdown →

11.

Brown, Harrison C., Christopher B. Doering, Roland W. Herzog, et al.. (2020). Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B. Human Gene Therapy. 31(19-20). 1114–1123. 23 indexed citations

12.

Pierce, Glenn F., John Pasi, Donna Coffin, et al.. (2020). Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table. Haemophilia. 26(3). 443–449. 16 indexed citations

13.

Balakrishnan, Balaji, Kavitha M. Lakshmi, Thenmozhi Mani, et al.. (2020). Prognostic plasma biomarkers of early complications and graft‐versus‐host disease in patients undergoing allogeneic hematopoietic stem cell transplantation. SHILAP Revista de lepidopterología. 1(1). 219–229. 12 indexed citations

14.

Doering, Christopher B., Gabriela Denning, Eli J. Fine, et al.. (2018). Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A. Human Gene Therapy. 29(10). 1183–1201. 45 indexed citations

15.

Korula, Anu, M. Kavitha, Marie Therese Manipadam, et al.. (2018). Peripheral T cell lymphoma. The Indian Journal of Medical Research. 147(5). 464–470. 7 indexed citations

16.

Oldenburg, Johannes, Roshni Kulkarni, Alok Srivastava, et al.. (2017). Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein. Haemophilia. 24(1). 77–84. 38 indexed citations

17.

Ganesan, Saravanan, Vairavan Lakshmanan, Nithya Balasundaram, et al.. (2017). Stromal-Cells Downregulate MiR-23a-5p Levels in Myeloid Leukemic Cells to Activate Protective-Autophagy Against Chemotherapeutic Agents. Blood. 130. 3780–3780. 1 indexed citations

18.

David, Sachin, Uday Kulkarni, Anu Korula, et al.. (2015). Coagulopathy in Acute Promyelocytic Leukemia: Strategies to Improve Assessment of Hemostatic Risk. Blood. 126(23). 3758–3758. 1 indexed citations

19.

Srivastava, Alok, et al.. (2012). Preputial/penile skin flap, as a dorsal onlay or tubularized flap: a versatile substitute for complex anterior urethral stricture. British Journal of Urology. 110(11c). E1101–8. 17 indexed citations

20.

Srivastava, Alok, et al.. (2012). Surgical complications of renal transplantation in patients with diabetes mellitus. 1(2). 157–158. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact